期刊文献+

雌激素在阿尔茨海默病患者的改变及其意义 被引量:13

下载PDF
导出
摘要 目的分析AD患者血清雌激素水平和内源性雌激素的改变,探讨雌激素水平与AD严重程度、病程及年龄的关系。方法采用1∶1病例配对的研究方法,通过面对面问卷调查对全部研究对象进行神经心理测验,包括MMSE、ADL、POD、FOM、WISE、HMT抑郁量表等;同时调查女性研究对象的初潮年龄、绝经年龄、怀孕次数及母乳喂养等;用放射免疫法测定血清性激素水平。结果AD组雌二醇水平(E2)明显低于对照组,有显著性差异(P<0.05);AD组血清雌二醇水平与痴呆严重程度和MMSE分值呈正相关,(P<0.05);AD组初潮年龄明显大于对照组,而绝经年龄明显早于对照组,有显著性差异(P<0.05);怀孕次数尽管在两组比较无统计学差异(P>0.05),但AD组仍少于对照组。结论AD组雌激素水平明显低于对照组,雌激素缺乏是AD的危险因素之一。
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2007年第3期179-182,共4页 Chinese Journal of Nervous and Mental Diseases
基金 国家九五科技攻关课题资助(编号96-906-05-01)
  • 相关文献

参考文献19

  • 1Cutler NR, Sramek JJ. Review of the next generation of Alzheimer's disease therapeutics:challenges for drug development. Prog Neuropsyehopharmaeol Biol Psychiatry,2001,25 ( 1 ) :25. 被引量:1
  • 2Waring SC, Rocca WA, Petersen RC, et al. Postmenopausal replacement therapy and risk of AD : A population based study. Neurology,1999,52(5) :965. 被引量:1
  • 3Eberling JI, Reed BR, Coleman JE, et al. Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology, 2000,55(6) :875. 被引量:1
  • 4Villarroya-Pastor MT. Profile of Alzheimer's disease in women. Rev Neurol,2001,32(12) : 1178. 被引量:1
  • 5Gao S, Hendrie HC, Hall KS, et al. The relationships between age,sex,and the incidence of dementia and Alzheimer disease:a meta-analysis. Arch Gen Psychiatry, 1998,55 (9) :809. 被引量:1
  • 6Jorm AF,Jolley D. The incidence of dementia:a meta-analysis. Neurology, 1998,51 ( 3 ) :728. 被引量:1
  • 7Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease. JAMA,2000,284(3) :307. 被引量:1
  • 8Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women. Randomized, double-blind, placebo-controlledtrial. Neurology, 2000,54 ( 5 ) :295. 被引量:1
  • 9Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestm on stroke postmenopausal women. JAMA ,2003,289(20) :2673. 被引量:1
  • 10Shunaker SA,Legault C,Rapp SR,et al. Estrogen plus progestm and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA, 2003,289 ( 20 ) :2651. 被引量:1

二级参考文献7

  • 1Yaffe K, Saways G, Lieberburg I, et al. Estrogen therapy in postmenopausal women effects on cognitive function and dementia. JAMA,1998,279(9)688. 被引量:1
  • 2Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system senile dementia (Alzheimer's thpe). J Steroid Biochem, 1989,34( 1 ~ 6) :521. 被引量:1
  • 3Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial. Neurology,2000,54(2) :295. 被引量:1
  • 4Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. JAMA,2000,283(8): 1007 被引量:1
  • 5Lerner A,Cole R,Debanne S,etal.Immunological and endocrine conditions in an Alzheimers disease case-control study[abstract],Neuroepidemiology,1995,14(4):307 被引量:1
  • 6Henderson VW,Paganini-Hill A,Emanuel CK,et al.Estrogen replace-ment therapy inolder women:Comparisons between Alzheimers disease cases and non-demented controlsubjects.Arch Neurol,1994,51(11):896 被引量:1
  • 7Jorn AF,Korten AE,Henderson AS.The prevalence of dementia:a quantitativeintegration of literature.Acta Psychiatr Scand,1987,76(6):465 被引量:1

共引文献8

同被引文献232

引证文献13

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部